AGP Picks
View all

Military Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Military Press Releases.

Press releases published on May 31, 2026

BriaCell Therapeutics Announces Pricing of Offering
Coastal Gateway Port Advances Strategic Canada–U.S. Shipbuilding and Defence Partnerships in Norfolk
Self OPEN EMDR: The Honest Pros and Cons of Doing It Without a Therapist
Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026
Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026
Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026
Viva! Marks World Milk Day by Announcing Major Dairy Documentary
Ruvi AI (RUVI) Introduces Staking in Its Latest Ecosystem Upgrade, Expanding Utility for Token Holders
What Riverside Families Are Looking for in Kids’ Birthday Party Places in 2026
Diana Shipping Inc. Sends Letter to Genco Shipping & Trading Shareholders Making the Case for Electing Six Independent Nominees With Proven Track Records of Creating Shareholder Value
Glyco Harmony Drops [URGENT REPORT 2026] GlycoHarmony Shocking Complete Scientific Breakdown of Benefits Everyone Is Talking
SlimTide Capsules [SHOCKING REPORT 2026] Slim Tide Latest Viral Weight-Loss Supplement Craze, Counterfeit Market Explosion, and Consumer Safety Concerns
CGTN: China-Africa ties at 70: From shared struggles to a common dream of modernization
Ruvi AI (RUVI) Announces Contributor Rewards Program That Pays Users to Help Train AI Models
Precede Biosciences Presents New ASCO 2026 Data Demonstrating Ability of Precede Bio Insight™ to Decode MET-Driven Biology and Resistance in Advanced NSCLC
Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer
Why AI Visibility Operating Systems Are Replacing Fragmented Marketing Strategies
Revolution Medicines Announces ASCO Plenary Presentation Highlighting Unprecedented Results from Pivotal Phase 3 RASolute 302 Clinical Trial of Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer
Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma
Replimune Presents Final First-in-Human Data for RP2 in Advanced Solid Tumors During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

Share this page:

Sign up for:

Military Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.